<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03120910</url>
  </required_header>
  <id_info>
    <org_study_id>FLEM0005</org_study_id>
    <nct_id>NCT03120910</nct_id>
    <nct_alias>NCT03075150</nct_alias>
  </id_info>
  <brief_title>Pleth Variability Index (PVI) to Predict Fluid Responsiveness</brief_title>
  <official_title>Validation of PVI as a Parameter to Predict Fluid Responsiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional data collection study to evaluate the ability of pleth variability index (PVI)&#xD;
      to predict fluid responsiveness in comparison with other dynamic parameters including pulse&#xD;
      pressure variation (PPV) and stroke volume variation (SVV).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      No subjects were enrolled into the validation portion of this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date type="Actual">December 15, 2016</start_date>
  <completion_date type="Actual">February 9, 2018</completion_date>
  <primary_completion_date type="Actual">February 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical utility of PVI</measure>
    <time_frame>1-5 hours</time_frame>
    <description>Correlation between PVI and SVV to assess PVI as a predictor for fluid responsiveness.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Test Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects are enrolled into this arm and will receive an investigational pulse CO-Oximeter sensor, including nasal sensors, with the same or similar technology and materials as the Masimo FDA cleared devices and sensors.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulse CO-Oximeter Sensor</intervention_name>
    <description>Investigational Pulse Oximeter Sensor will measure hemoglobin (SpHb), pulse rate (PR), perfusion index (PI), pleth variability index (PVI), oxygen reserve index (ORI), etc.</description>
    <arm_group_label>Test Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Scheduled for elective surgery requiring general anesthesia and mechanical ventilation&#xD;
&#xD;
          -  Arterial line and Swan-Ganz catheter placement indicated as part of the scheduled&#xD;
             surgical procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with surgeries at or around site of sensor placement or skin abnormalities&#xD;
             affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue,&#xD;
             burn, fungal infection, substantial skin breakdown, nail polish, or acrylic nails that&#xD;
             would prevent monitoring of pulse-oximeter physiological parameters during the study&#xD;
&#xD;
          -  Patients with cardiac arrhythmias&#xD;
&#xD;
          -  Patients with intracardiac shunts&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UC Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2017</study_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

